Next, we focused on one distinctive gene cluster that contained transforming growth factor beta 2 (TGFB2) and interleukin-10 (IL10) (Fig. 1c), which appeared to be driven by the recurrence of selective copy number gain in multiple tumor types. Here, TGFB2 is linked to neoplasm.